Home › Funds › Atle Fund Management AB › IRON
Atle Fund Management AB position in IRON
Disc Medicine, Inc. · Health Care
Atle Fund Management AB reported holding 43,682 shares of IRON (Disc Medicine, Inc.) in its Q3 2026 13F filing — a position valued at US$2.9M, representing 0.77% of its reported portfolio and ranking #35 among its reported holdings. Atle Fund Management AB has disclosed IRON holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR
How Atle Fund Management AB's IRON position evolved
Atle Fund Management AB first disclosed a stake in IRON in Q2 2025 at 24,652 shares (US$1.3M). The position peaked in Q4 2025 at 47,967 shares, worth US$3.8M. Across 6 filings, Atle Fund Management AB increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 43,682 shares valued at US$2.9M. Notable position changes include a 85% increase in Q3 2025 (shares rose 20% over the following quarter), a 124% increase in Q1 2026 (shares rose 14% over the following quarter), a 59% trim in Q2 2026 (shares fell 11% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 24.65K | $1.31M | New |
| Q3 2025 | 45.69K | $320.53K | Add |
| Q4 2025 | 47.97K | $3.81M | Add |
| Q1 2026 | 107.25K | $3.19M | Add |
| Q2 2026 | 43.68K | $3.19M | Reduce |
| Q3 2026 | 43.68K | $2.86M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IRON and 13F data
IRON (Disc Medicine, Inc.) is a Health Care company. 42 other funds we track also report a position in IRON — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$179.2M), Vestal Point Capital, LP (US$113.4M), Atlas Venture Life Science Advisors, LLC (US$110.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IRON
- RA CAPITAL MANAGEMENT, L.P. 2.45M sh · $179.21M · Q2 2026
- Vestal Point Capital, LP 1.55M sh · $113.37M · Q2 2026
- Atlas Venture Life Science Advisors, LLC 1.51M sh · $110.72M · Q2 2026
- Frazier Life Sciences Management, L.P. 1.35M sh · $99.09M · Q2 2026
- TCG Crossover Management, LLC 1.34M sh · $98.14M · Q2 2026
- BVF INC/IL 1.15M sh · $84.38M · Q2 2026
- Logos Global Management LP 875.00K sh · $64.00M · Q2 2026
- Opaleye Management Inc. 855.00K sh · $62.53M · Q2 2026
- Siren, L.L.C. 888.40K sh · $58.15M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 657.00K sh · $48.05M · Q2 2026
- Bellevue Group AG 560.00K sh · $40.96M · Q2 2026
- Saturn V Capital Management LP 524.73K sh · $38.38M · Q2 2026
More on Atle Fund Management AB
FAQ
How long has Atle Fund Management AB held IRON?
Atle Fund Management AB has disclosed IRON holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
What is Atle Fund Management AB's current position in IRON?
As of Q3 2026, Atle Fund Management AB holds 43.68K shares of IRON (Disc Medicine, Inc.), valued at $2.86M, representing 0.77% of its reported portfolio and ranking #35.
Has Atle Fund Management AB been buying or selling IRON?
In the latest 13F filing (Q3 2026), Atle Fund Management AB held unchanged its position in IRON. The position peaked in Q4 2025 at 47.97K shares.
Which other funds hold IRON?
Other major institutional holders of IRON include RA CAPITAL MANAGEMENT, L.P., Vestal Point Capital, LP, Atlas Venture Life Science Advisors, LLC, among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.